| IL2RB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aliases | IL2RB, CD122, IL15RB, P70-75, interleukin 2 receptor subunit beta, IMD63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| External IDs | OMIM: 146710; MGI: 96550; GeneCards: IL2RB | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Wikidata | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interleukin-2 receptor subunit beta is a protein that in humans is encoded by the IL2RB gene. Also known as CD122; IL15RB; P70-75.
The interleukin 2 receptor, which is involved in T cell-mediated immune responses, is present in 3 forms with respect to ability to bind interleukin 2. The low affinity form is a monomer of the alpha subunit (also called CD25) and is not involved in signal transduction. The intermediate affinity form consists of a gamma/beta subunit heterodimer, while the high affinity form consists of an alpha/beta/gamma subunit heterotrimer. Both the intermediate and high affinity forms of the receptor are involved in receptor-mediated endocytosis and transduction of mitogenic signals from interleukin 2. The protein encoded by this gene represents the beta subunit and is a type I membrane protein.
This protein also forms one of the three subunits of the IL-15 receptor.
Activation of the receptor increases proliferation of CD8+ effector T cells.
IL2RB has been shown to interact with:
IL2RB-mediated interleukin-15 (IL-15) signaling has been implicated in the pathogenesis of celiac disease. Increased IL-15 signaling promotes activation of intraepithelial lymphocytes, epithelial injury, and persistent intestinal inflammation, including in some patients who remain symptomatic despite adherence to a gluten-free diet.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.